重组人内皮抑素联合应用5氟脲嘧啶对胃癌裸鼠移植瘤的影响

来源 :中华普通外科杂志 | 被引量 : 0次 | 上传用户:JK0803_zhouli
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的探讨重组人内皮抑素(recombinanthumanendostatin, rhES)与5氟脲嘧啶(5 fluorouracil, 5 FU)联合应用对胃癌裸鼠移植瘤生长的抑制作用。方法建立胃癌异位移植BALB/C裸鼠模型,分为4组,每组6只。分别注射生理盐水,腹腔内注射5 FU(10mg/kg),rhES组瘤周注射rhES(2mg/kg)同时给予5 FU与rhES,每天1次,连用10d。计算肿瘤体积、抑瘤率及肿瘤缩小率,检测肿瘤组织血管内皮生长因子(VEGF)、碱性成纤维生长因子(bFGF)、血管内皮生长因子C(VEGF C)、Ⅷ因子相关抗原(FⅧAg)、增殖细胞核抗原(PCNA)、bcl 2表达及肿瘤细胞凋亡指数(AI)。结果rhES+5 FU组肿瘤体积为(43±2)mm3, 5 FU组为(169±45)mm3, rhES组为(95±28)mm3,对照组为(1057±114)mm3 (P<0 01 )。抑瘤率为99 6%,肿瘤缩小率为98 2%。用药前rhES+5 FU组肿瘤体积为( 207±50 )mm3,比5 FU组与rhES组下降更迅速(P<0 01 )。rhES+5 FU组与5 FU组VEGF、bFGF及VEGF C表达强度均为0 ~+;rhES+5 FU组PCNA及bcl 2表达最弱;rhES+5 FU组AI为11 7±1 1, 5 FU组为6 2±0 6,rhES组为5 8±0 8,对照组为2 4±0 6(P<0 01)。微血管密度在rhES+5 FU组为8 9±2 5,rhES组为10 0±1 5,均低于5 FU组(27 3±1 7)与对照组(29 9±2 3) (P<0 01 )。结论联合应用5 FU及rhES能显著抑制胃癌? Objective To investigate the inhibitory effect of recombinant human interleukin (rhES) combined with 5 fluorouracil (5 FU) on the growth of transplanted gastric cancer in nude mice. Methods BALB / C nude mice models of gastric cancer were established. They were divided into 4 groups with 6 in each. Rats were injected with 5 FU (10 mg / kg) intraperitoneally and rhFS (2 mg / kg) given concurrently with 5 FU and rhES once daily for 10 days. The tumor volume, tumor inhibition rate and tumor shrinkage rate were calculated. The expression of vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), vascular endothelial growth factor C (VEGF C), factor Ⅷ related antigen (FⅧAg) , Proliferating cell nuclear antigen (PCNA), bcl 2 expression and tumor cell apoptosis index (AI). Results The tumor volume of the rhES + 5 FU group was (43 ± 2) mm3, that of the 5 FU group was (169 ± 45) mm3, that of the rhES + 5 FU group was (95 ± 28) mm3, and that of the control group was (1057 ± 114) mm3 01). The tumor inhibition rate was 99.6% and the tumor reduction rate was 98.2%. The tumor volume of rhES + 5 FU group was (207 ± 50) mm3 before treatment, which was more rapid than that of 5 FU group and rhES group (P <0.01). The expressions of VEGF, bFGF and VEGF C in rhES + 5 FU group and 5 FU group were all 0 ~ +. The expression of PCNA and bcl 2 in rhES + 5 FU group was the weakest. The AI ​​in rhES + 5 FU group was 11 7 ± 1 1, 5 6 2 ± 0 6 in the FU group, 58 ± 0 8 in the rhES group, and 24 ± 0 6 in the control group (P <0.01). Microvessel density was 89 ± 25 in rhES + 5 FU group and 100 ± 1 5 in rhES group, both of which were lower than those in 5 FU group (27 3 ± 1 7) and control group (29 9 ± 2 3) (P < 0 01). Conclusion Combination of 5 FU and rhES can significantly inhibit gastric cancer?
其他文献
目的探讨中国北方地区汉族人群中的雌激素α受体(ERα)的XbaⅠ和PvuⅡ基因多态性与乳腺癌的关系。方法选取138例女性乳腺癌患者和140例年龄、性别相匹配的健康对照,应用RFLP
目的观察乳腺癌患者BRCA1基因变异.方法测序分析35例乳腺癌患者和10名正常女性BRCA1基因的全长第11外显子共3 427 bp,然后与Gene Bank记录的BRCA1正常序列比较.结果 35名患者
目的 评价Tacrolimus(FK5 0 6 )和细胞毒性T淋巴相关抗原4免疫球蛋白(CTLA4Ig)转基因腺病毒(AdCTLA4Ig)在耐受诱导中的作用。方法 按照是否接受FK5 0 6处理、心脏移植后有
目的:利用荧光极化原理,在液相系统内建立基于Bcl-2/Bak相互作用模式的高通量药物筛选体系。方法:在液相系统内建立Bcl-2蛋白和多肽的相互作用体系,用光度计检测荧光极化值,
目的分析乳腺癌细胞系的基质金属蛋白酶-2(MMP-2)和纤维粘连蛋白(FN) mRNA表达及蛋白表达与乳腺癌转移的关系,阐明MMP-2和FN在乳腺癌转移中的作用.方法采用荧光定量逆转录-聚
目的探讨多巴反应性肌张力障碍(DRD)的病因、临床特点及治疗,加强对该病的认识。方法对15例DRD患者的临床资料进行回顾性分析。结果平均发病年龄11.5岁,平均病程8.9年,均为慢
目的观察20~80岁健康女性血清骨特异性碱性磷酸酶(sBAP)、血清和尿液中I型胶原羧基末端肽(sCTX和uCTX)随年龄变化的规律及其与腰椎正位骨密度(BMD)之间的关系.方法用ELISA法测
目的构建siRNA体内表达载体pSilence-2.1-U6-siRNA,筛选出抑制甲硫氨酸腺苷转移酶(MAT)2A表达的有效靶序列,为MAT2A的功能研究奠定了基础.方法以MAT2A为目的基因,以产生siRNA
目的确定造血干细胞相关基因HSPC016的表达与毛乳头细胞凝集性生长的关系.方法对凝集性生长的人毛乳头细胞、非凝集性生长的人毛乳头细胞和人真皮成纤维细胞分别进行细胞内mR
目前,手术治疗仍是直肠癌治疗中的首选。随着人们对直肠癌生物学特性的重新认识,以及20世纪60年代吻合器的发明应用,越来越多的低位直肠癌得以进行保肛治疗,但术后局部复发是